Patent · US Active

Molecules and methods of using same for treating MCP-1/CCR2 associated diseases

US8388962B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2006
Grant dateMar 5, 2013
Priority date
Expiry dateMay 22, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Molecules and compositions including same for the isolation of MCP-1 and treatment of CCR2/MCP-1 associated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.